How about EXEL? This week we will get more data on XL184 as abstracts release Tuesday at 6:00 PM ET. Thursday there will be a webcast to discuss the data starting at 6:30 AM ET (1.5Hr). The "n" should jump 2x-3x and the treatment term increase substantially. I am guessing that bone met resolution in CRPC will top 90% (early data was 19/20). Of course, the data is early and there is always the question whether it holds up. Stock has had a substantial move since biomaven mentioned it. So even with good results it may be vulnerable to profit taking. EXEL is "cleaning" MNTA's "clock" - to turn one of DD's phrases around. :-) ij